FIELD: pharmacology.
SUBSTANCE: invention proposes employment of fluorinated triazoles having formula I:
to suppress pain and affect dysfunctions and disorder of attention.
EFFECT: increased efficiency and bioavailability.
5 cl
| Title | Year | Author | Number |
|---|---|---|---|
| MONOHYDROXYCARBAMAZEPINE FOR MEDICAL PREPARATION FOR AFFECTIVE AND ATTENTION DISORDERS AND NEUROPATHIC PAIN | 2002 |
|
RU2353365C2 |
| DERIVATIVE OF PYRROLIDINE ACETAMIDE OR ITS COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | 2000 |
|
RU2261093C2 |
| ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS (MGLUR 5) FOR TREATMENT OF PAIN AND ANXIETY STATE | 1999 |
|
RU2232017C2 |
| CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
| SIGMA-RECEPTOR LIGANDS FOR PREVENTING OR TREATING PAIN CAUSED BY CHEMOTHERAPY | 2010 |
|
RU2543382C2 |
| NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
| -E-10-OH-NT COMPOSITIONS AND METHOD FOR SYNTHESIS AND USE THEREOF | 2008 |
|
RU2469715C2 |
| ESLICARBAZEPINE ACETATE AND METHODS FOR APPLYING THEREOF | 2005 |
|
RU2417085C2 |
| NEW APPLICATION OF UNITED AGONISTS 5-HT AND INHIBITORS OF SEROTONIN REVERSE CAPTURE | 2001 |
|
RU2302243C2 |
| METHOD FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES WITH TRADIPITANT | 2018 |
|
RU2797248C2 |
